J0285 Injection, amphotericin b, 50 mg

Billable / valid for submission HCPCS Release 2026Q3

Short description: Amphotericin b

Version history

Related codes in J02

• J0202 Injection, alemtuzumab, 1 mg
• J0206 Injection, allopurinol sodium, 1 mg
• J0207 Injection, amifostine, 500 mg
• J0208 Injection, sodium thiosulfate (pedmark), 100 mg
• J0209 Injection, sodium thiosulfate (hope), 100 mg
• J0210 Injection, methyldopate hcl, up to 250 mg
• J0211 Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote)
• J0216 Injection, alfentanil hydrochloride, 500 micrograms
• J0217 Injection, velmanase alfa-tycv, 1 mg
• J0218 Injection, olipudase alfa-rpcp, 1 mg
• J0219 Injection, avalglucosidase alfa-ngpt, 4 mg
• J0220 Injection, alglucosidase alfa, 10 mg, not otherwise specified
• J0221 Injection, alglucosidase alfa, (lumizyme), 10 mg
• J0222 Injection, patisiran, 0.1 mg
• J0223 Injection, givosiran, 0.5 mg
• J0224 Injection, lumasiran, 0.5 mg
• J0225 Injection, vutrisiran, 1 mg
• J0248 Injection, remdesivir, 1 mg
• J0256 Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mg
• J0257 Injection, alpha 1 proteinase inhibitor (human), (glassia), 10 mg

All J02 codes →